The National Pharmacy Association (NPA) warned of a possible 'explosion in the unlicensed sale of medication online', with people risking their health by purchasing Ozempic and Wegovy without proper checks. Our community members are treated to special offers, promotions and adverts from us and our partners. You can check out at any time.
More info Pharmacy leaders have sounded the alarm, urging individuals to steer clear of purchasing counterfeit weight-loss injections online, as shortages of Ozempic are anticipated to continue into the next year. The National Pharmacy Association (NPA) has issued a stark warning about a potential "explosion in the unlicensed sale of medication online", highlighting the dangers of acquiring Ozempic and Wegovy (semaglutide) without appropriate medical oversight. These weight-loss jabs have soared in popularity, fuelled by social media's before-and-after fat loss showcases and some celebrity endorsements.
READ MORE: Car insurance prices drop for the first time in two years following massive price hike While Ozempic is prescribed on the NHS for type 2 diabetes patients, Wegovy is available through specialist weight management services for weight loss, subject to stringent eligibility criteria. Pharmacists are grappling with an Ozempic shortage, driven by surging demand and off-label prescriptions for obesity. Produced by Novo Nordisk, Ozempic aids in blood sugar regulation for those with Type 2 diabetes, but its appetite-suppressing effects have.